Recent News

• 04.01.2025 - Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
• 04.01.2025 - Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
• 04.01.2025 - Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
• 03.18.2025 - Eton Pharmaceuticals Investor Day and Fourth Quarter 2024 Earnings Results
• 03.18.2025 - Eton Pharmaceuticals Investor Day and Fourth Quarter 2024 Earnings Results
• 03.18.2025 - Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
• 03.18.2025 - Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
• 03.18.2025 - Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
• 03.14.2025 - Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
• 03.14.2025 - Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Recent Filings

• 04.01.2025 - EX-99.1 EX-99.1
• 04.01.2025 - 8-K Current report
• 03.18.2025 - 8-K Current report
• 03.18.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.18.2025 - 8-K Current report
• 03.18.2025 - EX-99.1 EX-99.1
• 03.18.2025 - EX-99.1 EX-99.1
• 03.14.2025 - 8-K Current report
• 03.14.2025 - EX-99.1 EX-99.1